Amelie Barre
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Correction: Deep remission improves the quality of life of patients with Crohn's disease and anoperineal fistula treated with darvadstrocel: results of a French pilot study.
Journal: Techniques in coloproctology
Published: April 30, 2026
Radiofrequency for the treatment of pilonidal disease: results of a French prospective pilot study.
Journal: Annals of coloproctology
Published: July 14, 2025
Effectiveness and Safety of Advanced Dual-Targeted Therapy in Refractory Perianal Crohn's Disease.
Journal: United European gastroenterology journal
Published: January 25, 2025
Elevated Fecal Lipocalin-2 Levels During Early Life Are Associated with Maternal Inflammatory Bowel Disease Diagnosis.
Journal: Digestive diseases and sciences
Published: November 01, 2024
Closing the internal opening with a rectal advancement flap increases the efficacy of mesenchymal stem cell injection for complex Crohn's disease anal fistulas.
Journal: Techniques in coloproctology
Published: May 26, 2024
Hemorrhoidal disease: Epidemiological study and analysis of predictive factors for surgical management.
Journal: Journal of visceral surgery
Published: April 05, 2024
Management of secondary lesions in ano-perineal Crohn's disease
Journal: La Revue du praticien
Published: June 08, 2023
Influence of Early Life Factors, including breast milk Composition, on the Microbiome of Infants Born to Mothers with and without Inflammatory Bowel Disease.
Journal: Journal of Crohn's & colitis
Published: January 30, 2023
Deep remission improves the quality of life of patients with Crohn's disease and anoperineal fistula treated with darvadstrocel: results of a French pilot study.
Journal: Techniques in coloproctology
Published: November 05, 2022
An increasingly frequent rash to be aware of….
Journal: Techniques in coloproctology
Published: August 02, 2022
Outcomes after double switching from originator Infliximab to biosimilar CT-P13 and biosimilar SB2 in patients with inflammatory bowel disease: a 12-month prospective cohort study.
Journal: Alimentary pharmacology & therapeutics
Published: October 22, 2020
Last Updated: 09/26/2026